Growth Equity Opportunities Fund IV, LLC

3 filings 3 distinct issuers Active 2018-03-05 → 2025-01-21

Track Record

Total filings

1 SCHEDULE · 2 SC

Distinct issuers

100% issuer diversity

Median stake

4.99%

32,679,649 avg shares

AI briefs cached

0/3

intent-classified filings

Filed	Form	Issuer	Stake	Shares
2025-01-21	SCHEDULE	Verona Pharma plc	4.99%	32,679,649	view →
2018-03-19	SC	Cascadian Therapeutics, Inc.	—	—	view →
2018-03-05	SC	ARCA biopharma, Inc.ORKA	—	—	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.